2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene has been researched along with egtazic acid in 1 studies
Studies (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Trials (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Recent Studies (post-2010) (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
---|---|---|---|---|---|
14 | 0 | 0 | 10,021 | 11 | 686 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rahwan, RG | 1 |
1 other study(ies) available for 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene and egtazic acid
Article | Year |
---|---|
The methylenedioxyindene calcium antagonists.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Calcium Channel Blockers; Calmodulin; Egtazic Acid; Heart; Heart Rate; Indenes; Myocardium; Sarcoplasmic Reticulum | 1985 |